- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Emedastine is a type of respiratory drug used to treat allergic rhinitis and conjunctivitis. It is a second-generation antihistamine, which means it is more effective than first-generation antihistamines in treating symptoms such as sneezing, itching, and watery eyes. It is available in both oral and topical forms, and is often used in combination with other medications to treat more severe cases of allergic rhinitis. Emedastine is generally well-tolerated, with few side effects.
The Emedastine market is a growing one, with many companies offering products containing the drug. These companies include major pharmaceutical companies such as Novartis, Merck, and Pfizer, as well as smaller companies such as Allergan and Teva Pharmaceuticals. Additionally, generic versions of the drug are available from many generic drug manufacturers. Show Less Read more